研究者詳細

顔写真

サクライ ミカ
櫻井 美佳
Mika Sakurai
所属
東北メディカル・メガバンク機構 人材育成部門
職名
准教授
学位
  • 博士(医学)(東京大学)

  • 修士(工学)(東京理科大学)

e-Rad 研究者番号
80508359

経歴 8

  • 2018年3月 ~ 継続中
    東北大学 東北メディカル・メガバンク機構 准教授

  • 2017年4月 ~ 2018年2月
    東北大学 東北メディカル・メガバンク機構 講師

  • 2015年4月 ~ 2017年3月
    日本医療研究開発機構 主幹

  • 2013年9月 ~ 2015年3月
    東北大学 東北メディカル・メガバンク機構 助教

  • 2007年11月 ~ 2013年8月
    東京大学 医科学研究所 助教

  • 2007年9月 ~ 2007年11月
    東京大学 医科学研究所 学術研究支援員

  • 2005年4月 ~ 2007年8月
    キュリー研究所 ポストドクトラルフェロー

  • 2003年4月 ~ 2005年3月
    国立がんセンター研究所 リサーチレジデント

︎全件表示 ︎最初の5件までを表示

学歴 3

  • 東京大学 医学系研究科

    1999年4月 ~ 2003年3月

  • 東京理科大学 基礎工学研究科

    1997年4月 ~ 1999年3月

  • 東京理科大学 基礎工学部

    1993年4月 ~ 1997年3月

所属学協会 3

  • 日本人類遺伝学会

  • 日本癌学会

  • 日本分子生物学会

研究キーワード 5

  • ゲノム医療

  • 細胞接着

  • 細胞浸潤

  • 細胞外マトリックス

  • 分子細胞生物学

研究分野 3

  • ライフサイエンス / 分子生物学 /

  • ライフサイエンス / 細胞生物学 /

  • ライフサイエンス / ゲノム生物学 /

論文 48

  1. The Health History of First-Degree Relatives’ Dyslipidemia Can Affect Preferences and Intentions following the Return of Genomic Results for Monogenic Familial Hypercholesterolemia 査読有り

    Tomoharu Tokutomi, Akiko Yoshida, Akimune Fukushima, Kayono Yamamoto, Yasushi Ishigaki, HIROSHI KAWAME, Nobuo Fuse, Fuji Nagami, Yoichi Suzuki, Mika Sakurai-Yageta, Akira Uruno, Kichiya Suzuki, Kozo Tanno, Hideki Ohmomo, Atsushi Shimizu, Masayuki Yamamoto, Makoto Sasaki

    Genes 2024年3月21日

    DOI: 10.3390/genes15030384  

  2. Study Profile of the Tsuruoka Metabolomics Cohort Study (TMCS) 査読有り

    Sei Harada, Miho Iida, Naoko Miyagawa, Aya Hirata, Kazuyo Kuwabara, Minako Matsumoto, Tomonori Okamura, Shun Edagawa, Yoko Kawada, Atsuko Miyake, Ryota Toki, Miki Akiyama, Atsuki Kawai, Daisuke Sugiyama, Yasunori Sato, Ryo Takemura, Kota Fukai, Yoshiki Ishibashi, Suzuka Kato, Ayako Kurihara, Mizuki Sata, Takuma Shibuki, Ayano Takeuchi, Shun Kohsaka, Mitsuaki Sawano, Satoshi Shoji, Yoshikane Izawa, Masahiro Katsumata, Koichi Oki, Shinichi Takahashi, Tsubasa Takizawa, Hiroshi Maruya, Yuji Nishiwaki, Ryo Kawasaki, Akiyoshi Hirayama, Takamasa Ishikawa, Rintaro Saito, Asako Sato, Tomoyoshi Soga, Masahiro Sugimoto, Masaru Tomita, Shohei Komaki, Hideki Ohmomo, Kanako Ono, Yayoi Otsuka-Yamasaki, Atsushi Shimizu, Yoichi Sutoh, Atsushi Hozawa, Kengo Kinoshita, Seizo Koshiba, Kazuki Kumada, Soichi Ogishima, Mika Sakurai-Yageta, Gen Tamiya, Toru Takebayashi

    Journal of Epidemiology 2024年1月

    出版者・発行元: Japan Epidemiological Association

    DOI: 10.2188/jea.je20230192  

    ISSN:0917-5040

    eISSN:1349-9092

  3. Design and Progress of Child Health Assessments at Community Support Centers in the Birth and Three-Generation Cohort Study of the Tohoku Medical Megabank Project.

    Tomoko Kobayashi, Mika Kobayashi, Naoko Minegishi, Masahiro Kikuya, Taku Obara, Mami Ishikuro, Chizuru Yamanaka, Tomomi Onuma, Keiko Murakami, Fumihiko Ueno, Aoi Noda, Akira Uruno, Junichi Sugawara, Kichiya Suzuki, Eiichi N Kodama, Yohei Hamanaka, Naho Tsuchiya, Mana Kogure, Naoki Nakaya, Makiko Taira, Mika Sakurai-Yageta, Toru Tamahara, Junko Kawashima, Maki Goto, Akihito Otsuki, Ritsuko Shimizu, Soichi Ogishima, Hiroaki Hashizume, Fuji Nagami, Tomohiro Nakamura, Atsushi Hozawa, Tadao Kobayashi, Nobuo Fuse, Shinichi Kuriyama, Shigeo Kure, Masayuki Yamamoto

    The Tohoku journal of experimental medicine 259 (2) 93-105 2023年1月20日

    DOI: 10.1620/tjem.2022.J103  

    詳細を見る 詳細を閉じる

    The Tohoku Medical Megabank Project (TMM) has been conducting a birth and three-generation cohort study (the BirThree Cohort Study). We recruited 73,529 pregnant women and their family members for this cohort study, which included 23,143 newborns and 9,459 of their siblings. We designed and are in the process of conducting three-step health assessments for each newborn at approximately ages of 5, 10 and 16. These health assessments are administered at seven community support centers. Trained genome medical research coordinators conduct physical examinations of and collect biological specimens from each participant. The Sendai Children's Health Square has been established as the headquarters for these child health assessments and is utilized to accumulate knowledge that can facilitate the proper practice of child health assessments. We designed all the relevant health assessments facilities to allow parents and their children to participate in the health assessments concomitantly. Our centers serve as places where child participants and their parents can feel at ease as a result of the implementation of safety measures and child hospitality measures. The TMM BirThree Cohort Study is in the process of conducting strategically detailed health assessments and genome analysis, which can facilitate studies concerning the gene-environment interactions relevant to noncommunicable diseases. Through these operations, our study allows for a significant depth of data to be collected in terms of the number of biospecimens under study and the comprehensiveness of both basic and clinical data alongside relevant family information.

  4. Trans-homophilic interaction of CADM1 promotes organ infiltration of T-cell lymphoma by adhesion to vascular endothelium. 国際誌

    Yutaka Kasai, Siew Pey Gan, Toko Funaki, Yuki Ohashi-Kumagai, Mizuki Tominaga, Shu-Jen Shiu, Daisuke Suzuki, Daisuke Matsubara, Takeharu Sakamoto, Mika Sakurai-Yageta, Takeshi Ito, Yoshinori Murakami

    Cancer science 113 (5) 1669-1678 2022年5月

    DOI: 10.1111/cas.15307  

    詳細を見る 詳細を閉じる

    The initial step of organ infiltration of malignant cells is the interaction with host vascular endothelial cells, which is often mediated by specific combinations of cell adhesion molecules. Cell adhesion molecule 1 (CADM1) is overexpressed in adult T-cell leukemia/lymphoma (ATL) and provides a cell-surface diagnostic marker. CADM1 promotes the adhesion of ATL cells to vascular endothelial cells and multiple organ infiltration in mice. However, its binding partner on host cells has not yet been identified. In this study, we show that CADM1 promotes transendothelial migration of ATL cells in addition to the adhesion to vascular endothelial cells. Moreover, CADM1 enhances liver infiltration of mouse T-cell lymphoma cells, EL4, after tail vein injection, whereas a CADM1 mutant lacking adhesive activity did not. Among the known CADM1-binding proteins expressed in primary endothelial cells, only CADM1 and CADM4 could induce morphological extension of ATL cells when plated onto glass coated with these proteins. Furthermore, CADM1-mediated liver infiltration of EL4 cells was canceled in conventional and vascular endothelium-specific Cadm1 knockout mice, whereas it was not canceled in Cadm4 knockout mice. These results suggest that CADM1 on host vascular endothelial cells is required for organ infiltration of ATL and other T-cell lymphomas expressing CADM1.

  5. A Pilot Study for Return of Individual Pharmacogenomic Results to Population-Based Cohort Study Participants.

    Kinuko Ohneda, Masahiro Hiratsuka, Hiroshi Kawame, Fuji Nagami, Yoichi Suzuki, Kichiya Suzuki, Akira Uruno, Mika Sakurai-Yageta, Yohei Hamanaka, Makiko Taira, Soichi Ogishima, Shinichi Kuriyama, Atsushi Hozawa, Hiroaki Tomita, Naoko Minegishi, Junichi Sugawara, Inaho Danjoh, Tomohiro Nakamura, Tomoko Kobayashi, Yumi Yamaguchi-Kabata, Shu Tadaka, Taku Obara, Eiji Hishimuma, Nariyasu Mano, Masaki Matsuura, Yuji Sato, Masateru Nakasone, Yohei Honkura, Jun Suzuki, Yukio Katori, Yoichi Kakuta, Atsushi Masamune, Yoko Aoki, Masaharu Nakayama, Shigeo Kure, Kengo Kinoshita, Nobuo Fuse, Masayuki Yamamoto

    JMA journal 5 (2) 177-189 2022年4月15日

    DOI: 10.31662/jmaj.2021-0156  

    詳細を見る 詳細を閉じる

    Introduction: Pharmacogenomic (PGx) testing results provide valuable information on drug selection and appropriate dosing, maximization of efficacy, and minimization of adverse effects. Although the number of large-scale, next-generation-sequencing-based PGx studies has recently increased, little is known about the risks and benefits of returning PGx results to ostensibly healthy individuals in research settings. Methods: Single-nucleotide variants of three actionable PGx genes, namely, MT-RNR1, CYP2C19, and NUDT15, were returned to 161 participants in a population-based Tohoku Medical Megabank project. Informed consent was obtained from the participants after a seminar on the outline of this study. The results were sent by mail alongside sealed information letter intended for clinicians. As an exception, genetic counseling was performed for the MT-RNR1 m.1555A > G variant carriers by a medical geneticist, and consultation with an otolaryngologist was encouraged. Questionnaire surveys (QSs) were conducted five times to evaluate the participants' understanding of the topic, psychological impact, and attitude toward the study. Results: Whereas the majority of participants were unfamiliar with the term PGx, and none had undergone PGx testing before the study, more than 80% of the participants felt that they could acquire basic PGx knowledge sufficient to understand their genomic results and were satisfied with their potential benefit and use in future prescriptions. On the other hand, some felt that the PGx concepts or terminology was difficult to fully understand and suggested that in-person return of the results was desirable. Conclusions: These results collectively suggest possible benefits of returning preemptive PGx information to ostensibly healthy cohort participants in a research setting.

  6. dbTMM: an integrated database of large-scale cohort, genome and clinical data for the Tohoku Medical Megabank Project. 国際誌

    Soichi Ogishima, Satoshi Nagaie, Satoshi Mizuno, Ryosuke Ishiwata, Keita Iida, Kazuro Shimokawa, Takako Takai-Igarashi, Naoki Nakamura, Sachiko Nagase, Tomohiro Nakamura, Naho Tsuchiya, Naoki Nakaya, Keiko Murakami, Fumihiko Ueno, Tomomi Onuma, Mami Ishikuro, Taku Obara, Shunji Mugikura, Hiroaki Tomita, Akira Uruno, Tomoko Kobayashi, Akito Tsuboi, Shu Tadaka, Fumiki Katsuoka, Akira Narita, Mika Sakurai, Satoshi Makino, Gen Tamiya, Yuichi Aoki, Ritsuko Shimizu, Ikuko N Motoike, Seizo Koshiba, Naoko Minegishi, Kazuki Kumada, Takahiro Nobukuni, Kichiya Suzuki, Inaho Danjoh, Fuji Nagami, Kozo Tanno, Hideki Ohmomo, Koichi Asahi, Atsushi Shimizu, Atsushi Hozawa, Shinichi Kuriyama, Nobuo Fuse, Teiji Tominaga, Shigeo Kure, Nobuo Yaegashi, Kengo Kinoshita, Makoto Sasaki, Hiroshi Tanaka, Masayuki Yamamoto

    Human genome variation 8 (1) 44-44 2021年12月10日

    DOI: 10.1038/s41439-021-00175-5  

    詳細を見る 詳細を閉じる

    To reveal gene-environment interactions underlying common diseases and estimate the risk for common diseases, the Tohoku Medical Megabank (TMM) project has conducted prospective cohort studies and genomic and multiomics analyses. To establish an integrated biobank, we developed an integrated database called "dbTMM" that incorporates both the individual cohort/clinical data and the genome/multiomics data of 157,191 participants in the Tohoku Medical Megabank project. To our knowledge, dbTMM is the first database to store individual whole-genome data on a variant-by-variant basis as well as cohort/clinical data for over one hundred thousand participants in a prospective cohort study. dbTMM enables us to stratify our cohort by both genome-wide genetic factors and environmental factors, and it provides a research and development platform that enables prospective analysis of large-scale data from genome cohorts.

  7. Construction and integration of three de novo Japanese human genome assemblies toward a population-specific reference

    Jun Takayama, Shu Tadaka, Kenji Yano, Fumiki Katsuoka, Chinatsu Gocho, Takamitsu Funayama, Satoshi Makino, Yasunobu Okamura, Atsuo Kikuchi, Sachiyo Sugimoto, Junko Kawashima, Akihito Otsuki, Mika Sakurai-Yageta, Jun Yasuda, Shigeo Kure, Kengo Kinoshita, Masayuki Yamamoto, Gen Tamiya

    Nature Communications 12 (1) 2021年12月

    出版者・発行元: Springer Science and Business Media LLC

    DOI: 10.1038/s41467-020-20146-8  

    eISSN:2041-1723

    詳細を見る 詳細を閉じる

    <title>Abstract</title>The complete human genome sequence is used as a reference for next-generation sequencing analyses. However, some ethnic ancestries are under-represented in the reference genome (e.g., GRCh37) due to its bias toward European and African ancestries. Here, we perform de novo assembly of three Japanese male genomes using &gt; 100× Pacific Biosciences long reads and Bionano Genomics optical maps per sample. We integrate the genomes using the major allele for consensus and anchor the scaffolds using genetic and radiation hybrid maps to reconstruct each chromosome. The resulting genome sequence, JG1, is contiguous, accurate, and carries the Japanese major allele at most loci. We adopt JG1 as the reference for confirmatory exome re-analyses of seven rare-disease Japanese families and find that re-analysis using JG1 reduces total candidate variant calls versus GRCh37 while retaining disease-causing variants. These results suggest that integrating multiple genomes from a single population can aid genome analyses of that population.

  8. Association between Serum Biotin Levels and Cedar Pollinosis in Japanese Schoolchildren

    Mika SAKURAI-YAGETA, Yoichi MASHIMO, Toshinobu KUROISHI, Rino ISHIHARA, Naoki SHIMOJO, Yoichi KOHNO, Yoshitaka OKAMOTO, Akira HATA, Yoichi SUZUKI

    Journal of Nutritional Science and Vitaminology 67 (4) 211-216 2021年8月31日

    出版者・発行元: Center for Academic Publications Japan

    DOI: 10.3177/jnsv.67.211  

    ISSN:0301-4800

    eISSN:1881-7742

  9. The return of individual genomic results to research participants: design and pilot study of Tohoku Medical Megabank Project. 国際誌

    Hiroshi Kawame, Akimune Fukushima, Nobuo Fuse, Fuji Nagami, Yoichi Suzuki, Mika Sakurai-Yageta, Jun Yasuda, Yumi Yamaguchi-Kabata, Kengo Kinoshita, Soichi Ogishima, Takako Takai, Shinichi Kuriyama, Atsushi Hozawa, Naoki Nakaya, Tomohiro Nakamura, Naoko Minegishi, Junichi Sugawara, Kichiya Suzuki, Hiroaki Tomita, Akira Uruno, Tomoko Kobayashi, Yayoi Aizawa, Tomoharu Tokutomi, Kayono Yamamoto, Kinuko Ohneda, Shigeo Kure, Yoko Aoki, Hideki Katagiri, Yasushi Ishigaki, Shojiro Sawada, Makoto Sasaki, Masayuki Yamamoto

    Journal of human genetics 67 (1) 9-17 2021年7月8日

    DOI: 10.1038/s10038-021-00952-8  

    詳細を見る 詳細を閉じる

    Certain large genome cohort studies attempt to return the individual genomic results to the participants; however, the implementation process and psychosocial impacts remain largely unknown. The Tohoku Medical Megabank Project has conducted large genome cohort studies of general residents. To implement the disclosure of individual genomic results, we extracted the potential challenges and obstacles. Major challenges include the determination of genes/disorders based on the current medical system in Japan, the storage of results, prevention of misunderstanding, and collaboration of medical professionals. To overcome these challenges, we plan to conduct multilayer pilot studies, which deal with different disorders/genes. We finally chose familial hypercholesterolemia (FH) as a target disease for the first pilot study. Of the 665 eligible candidates, 33.5% were interested in the pilot study and provided consent after an educational "genetics workshop" on the basic genetics and medical facts of FH. The genetics professionals disclosed the results to the participants. All positive participants were referred to medical care, and a serial questionnaire revealed no significant psychosocial distress after the disclosure. Return of genomic results to research participants was implemented using a well-prepared protocol. To further elucidate the impact of different disorders, we will perform multilayer pilot studies with different disorders, including actionable pharmacogenomics and hereditary tumor syndromes.

  10. Japonica Array NEO with increased genome-wide coverage and abundant disease risk SNPs

    Mika Sakurai-Yageta, Kazuki Kumada, Chinatsu Gocho, Satoshi Makino, Akira Uruno, Shu Tadaka, Ikuko N Motoike, Masae Kimura, Shin Ito, Akihito Otsuki, Akira Narita, Hisaaki Kudo, Yuichi Aoki, Inaho Danjoh, Jun Yasuda, Hiroshi Kawame, Naoko Minegishi, Seizo Koshiba, Nobuo Fuse, Gen Tamiya, Masayuki Yamamoto, Kengo Kinoshita

    The Journal of Biochemistry 2021年5月13日

    出版者・発行元: Oxford University Press (OUP)

    DOI: 10.1093/jb/mvab060  

    ISSN:0021-924X

    eISSN:1756-2651

    詳細を見る 詳細を閉じる

    <title>Abstract</title> Ethnic-specific SNP arrays are becoming more important to increase the power of genome-wide association studies in diverse population. In the Tohoku Medical Megabank Project, we have been developing a series of Japonica Arrays (JPA) for genotyping participants based on reference panels constructed from whole-genome sequence data of the Japanese population. Here, we designed a novel version of the SNP array for the Japanese population, called Japonica Array NEO (JPA NEO), comprising a total of 666,883 markers. Among them, 654,246 tag SNPs of autosomes and X chromosome were selected from an expanded reference panel of 3,552 Japanese, 3.5KJPNv2, using pairwise r2 of linkage disequilibrium measures. Additionally, 28,298 markers were included for the evaluation of previously identified disease risk markers from the literature and databases, and those present in the Japanese population were extracted using the reference panel. Through genotyping 286 Japanese samples, we found that the imputation quality r2 and INFO score in the minor allele frequency bin &amp;gt;2.5–5% were &amp;gt;0.9 and &amp;gt;0.8, respectively, and &amp;gt;12 million markers were imputed with an INFO score &amp;gt;0.8. From these results, JPA NEO is a promising tool for genotyping the Japanese population with genome-wide coverage, contributing to the development of genetic risk scores.

  11. Design and Progress of Oral Health Examinations in the Tohoku Medical Megabank Project

    Akito Tsuboi, Hiroyuki Matsui, Naru Shiraishi, Takahisa Murakami, Akihito Otsuki, Junko Kawashima, Tomomi Kiyama, Toru Tamahara, Maki Goto, Shihoko Koyama, Junichi Sugawara, Eiichi N. Kodama, Hirohito Metoki, Atsushi Hozawa, Shinichi Kuriyama, Hiroaki Tomita, Masahiro Kikuya, Naoko Minegishi, Kichiya Suzuki, Seizo Koshiba, Gen Tamiya, Nobuo Fuse, Yuichi Aoki, Takako Takai-Igarashi, Soichi Ogishima, Tomohiro Nakamura, Mika Sakurai-Yageta, Fuji Nagami, Kengo Kinoshita, Shigeo Kure, Ritsuko Shimizu, Keiichi Sasaki, Masayuki Yamamoto

    The Tohoku Journal of Experimental Medicine 251 (2) 97-115 2020年

    DOI: 10.1620/tjem.251.97  

    ISSN:0040-8727

    eISSN:1349-3329

  12. Identification of two novel breast cancer loci through large-scale genome-wide association study in the Japanese population. 国際誌 査読有り

    Low SK, Chin YM, Ito H, Matsuo K, Tanikawa C, Matsuda K, Saito H, Sakurai-Yageta M, Nakaya N, Shimizu A, Nishizuka SS, Yamaji T, Sawada N, Iwasaki M, Tsugane S, Takezaki T, Suzuki S, Naito M, Wakai K, Kamatani Y, Momozawa Y, Murakami Y, Inazawa J, Nakamura Y, Kubo M, Katagiri T, Miki Y

    Scientific reports 9 (1) 17332-17332 2019年11月

    DOI: 10.1038/s41598-019-53654-9  

  13. Establishment of Integrated Biobank for Precision Medicine and Personalized Healthcare: The Tohoku Medical Megabank Project. 査読有り

    Fuse N, Sakurai-YagetaM, Katsuoka F, Danjoh I, Shimizu R, Tamiya G, Nagami F, Kawame H, Higuchi S, Kinoshita K, Kure S, Yamamoto M

    JMA Journal 2 (2) 113-122 2019年9月

    DOI: 10.31662/jmaj.2019-0014.  

  14. Cohort Profile: Tohoku Medical Megabank Project Birth and Three-Generation Cohort Study (TMM BirThree Cohort Study): Rationale, Progress and Perspective. 国際誌 査読有り

    Kuriyama S, Metoki H, Kikuya M, Obara T, Ishikuro M, Yamanaka C, Nagai M, Matsubara H, Kobayashi T, Sugawara J, Tamiya G, Hozawa A, Nakaya N, Tsuchiya N, Nakamura T, Narita A, Kogure M, Hirata T, Tsuji I, Nagami F, Fuse N, Arai T, Kawaguchi Y, Higuchi S, Sakaida M, Suzuki Y, Osumi N, Nakayama K, Ito K, Egawa S, Chida K, Kodama E, Kiyomoto H, Ishii T, Tsuboi A, Tomita H, Taki Y, Kawame H, Suzuki K, Ishii N, Ogishima S, Mizuno S, Takai-Igarashi T, Minegishi N, Yasuda J, Igarashi K, Shimizu R, Nagasaki M, Tanabe O, Koshiba S, Hashizume H, Motohashi H, Tominaga T, Ito S, Tanno K, Sakata K, Shimizu A, Hitomi J, Sasaki M, Kinoshita K, Tanaka H, Kobayashi T, Kure S, Yaegashi N, Yamamoto M, Tohoku Medical Megabank Project, Study Group

    International journal of epidemiology 2019年8月25日

    DOI: 10.1093/ije/dyz169  

    ISSN:0300-5771

  15. A training and education program for genome medical research coordinators in the genome cohort study of the Tohoku Medical Megabank Organization. 査読有り

    M Sakurai-Yageta, Hiroshi Kawame, Shinichi Kuriyama, Atsushi Hozawa, Naoki Nakaya, Fuji Nagami, Naoko Minegishi, Soichi Ogishima, Takako Takai-Igarashi, Inaho Danjoh, Taku Obara, Mami Ishikuro, Tomoko Kobayashi, Yayoi Aizawa, Rino Ishihara, Masayuki Yamamoto, Yoichi Suzuki

    BMC Medical Education 19 (1) 297 2019年8月

    DOI: 10.1186/s12909-019-1725-5.  

    ISSN:1472-6920

  16. Genome analyses for the Tohoku Medical Megabank Project towards establishment of personalized healthcare. 国際誌 査読有り

    Jun Yasuda, Kengo Kinoshita, Fumiki Katsuoka, Inaho Danjoh, Mika Sakurai-Yageta, Ikuko N Motoike, Yoko Kuroki, Sakae Saito, Kaname Kojima, Matsuyuki Shirota, Daisuke Saigusa, Akihito Otsuki, Junko Kawashima, Yumi Yamaguchi-Kabata, Shu Tadaka, Yuichi Aoki, Takahiro Mimori, Kazuki Kumada, Jin Inoue, Satoshi Makino, Miho Kuriki, Nobuo Fuse, Seizo Koshiba, Osamu Tanabe, Masao Nagasaki, Gen Tamiya, Ritsuko Shimizu, Takako Takai-Igarashi, Soichi Ogishima, Atsushi Hozawa, Shinichi Kuriyama, Junichi Sugawara, Akito Tsuboi, Hideyasu Kiyomoto, Tadashi Ishii, Hiroaki Tomita, Naoko Minegishi, Yoichi Suzuki, Kichiya Suzuki, Hiroshi Kawame, Hiroshi Tanaka, Yasuyuki Taki, Nobuo Yaegashi, Shigeo Kure, Fuji Nagami, Kenjiro Kosaki, Yoichi Sutoh, Tsuyoshi Hachiya, Atsushi Shimizu, Makoto Sasaki, Masayuki Yamamoto

    Journal of biochemistry 165 (2) 139-158 2019年2月1日

    DOI: 10.1093/jb/mvy096  

    詳細を見る 詳細を閉じる

    Personalized healthcare (PHC) based on an individual's genetic make-up is one of the most advanced, yet feasible, forms of medical care. The Tohoku Medical Megabank (TMM) Project aims to combine population genomics, medical genetics and prospective cohort studies to develop a critical infrastructure for the establishment of PHC. To date, a TMM CommCohort (adult general population) and a TMM BirThree Cohort (birth+three-generation families) have conducted recruitments and baseline surveys. Genome analyses as part of the TMM Project will aid in the development of a high-fidelity whole-genome Japanese reference panel, in designing custom single-nucleotide polymorphism (SNP) arrays specific to Japanese, and in estimation of the biological significance of genetic variations through linked investigations of the cohorts. Whole-genome sequencing from >3,500 unrelated Japanese and establishment of a Japanese reference genome sequence from long-read data have been done. We next aim to obtain genotype data for all TMM cohort participants (>150,000) using our custom SNP arrays. These data will help identify disease-associated genomic signatures in the Japanese population, while genomic data from TMM BirThree Cohort participants will be used to improve the reference genome panel. Follow-up of the cohort participants will allow us to test the genetic markers and, consequently, contribute to the realization of PHC.

  17. 3.5KJPNv2: an allele frequency panel of 3552 Japanese individuals including the X chromosome. 国際誌 査読有り

    Shu Tadaka, Fumiki Katsuoka, Masao Ueki, Kaname Kojima, Satoshi Makino, Sakae Saito, Akihito Otsuki, Chinatsu Gocho, Mika Sakurai-Yageta, Inaho Danjoh, Ikuko N Motoike, Yumi Yamaguchi-Kabata, Matsuyuki Shirota, Seizo Koshiba, Masao Nagasaki, Naoko Minegishi, Atsushi Hozawa, Shinichi Kuriyama, Atsushi Shimizu, Jun Yasuda, Nobuo Fuse, Gen Tamiya, Masayuki Yamamoto, Kengo Kinoshita

    Human genome variation 6 (28) 28-28 2019年

    DOI: 10.1038/s41439-019-0059-5  

    詳細を見る 詳細を閉じる

    The first step towards realizing personalized healthcare is to catalog the genetic variations in a population. Since the dissemination of individual-level genomic information is strictly controlled, it will be useful to construct population-level allele frequency panels with easy-to-use interfaces. In the Tohoku Medical Megabank Project, we sequenced nearly 4000 individuals from a Japanese population and constructed an allele frequency panel of 3552 individuals after removing related samples. The panel is called the 3.5KJPNv2. It was constructed by using a standard pipeline including the 1KGP and gnomAD algorithms to reduce technical biases and to allow comparisons to other populations. Our database is the first large-scale panel providing the frequencies of variants present on the X chromosome and on the mitochondria in the Japanese population. All the data are available on our original database at https://jmorp.megabank.tohoku.ac.jp.

  18. Biobank Establishment and Sample Management in the Tohoku Medical Megabank Project 査読有り

    Naoko Minegishi, Ichiko Nishijima, Takahiro Nobukuni, Hisaaki Kudo, Noriko Ishida, Takahiro Terakawa, Kazuki Kumada, Riu Yamashita, Fumiki Katsuoka, Soichi Ogishima, Kichiya Suzuki, Makoto Sasaki, Mamoru Satoh, Tohoku Medical Megabank Project Study Group, Masayuki Yamamoto

    The Tohoku Journal of Experimental Medicine 248 (1) 45-55 2019年

    出版者・発行元: Tohoku University Medical Press

    DOI: 10.1620/tjem.248.45  

    ISSN:0040-8727

    eISSN:1349-3329

  19. Regional genetic differences among Japanese populations and performance of genotype imputation using whole-genome reference panel of the Tohoku Medical Megabank Project. 国際誌 査読有り

    Jun Yasuda, Fumiki Katsuoka, Inaho Danjoh, Yosuke Kawai, Kaname Kojima, Masao Nagasaki, Sakae Saito, Yumi Yamaguchi-Kabata, Shu Tadaka, Ikuko N Motoike, Kazuki Kumada, Mika Sakurai-Yageta, Osamu Tanabe, Nobuo Fuse, Gen Tamiya, Koichiro Higasa, Fumihiko Matsuda, Nobufumi Yasuda, Motoki Iwasaki, Makoto Sasaki, Atsushi Shimizu, Kengo Kinoshita, Masayuki Yamamoto

    BMC genomics 19 (1) 551-551 2018年7月24日

    DOI: 10.1186/s12864-018-4942-0  

    詳細を見る 詳細を閉じる

    BACKGROUND: Genotype imputation from single-nucleotide polymorphism (SNP) genotype data using a haplotype reference panel consisting of thousands of unrelated individuals from populations of interest can help to identify strongly associated variants in genome-wide association studies. The Tohoku Medical Megabank (TMM) project was established to support the development of precision medicine, together with the whole-genome sequencing of 1070 human genomes from individuals in the Miyagi region (Northeast Japan) and the construction of the 1070 Japanese genome reference panel (1KJPN). Here, we investigated the performance of 1KJPN for genotype imputation of Japanese samples not included in the TMM project and compared it with other population reference panels. RESULTS: We found that the 1KJPN population was more similar to other Japanese populations, Nagahama (south-central Japan) and Aki (Shikoku Island), than to East Asian populations in the 1000 Genomes Project other than JPT, suggesting that the large-scale collection (more than 1000) of Japanese genomes from the Miyagi region covered many of the genetic variations of Japanese in mainland Japan. Moreover, 1KJPN outperformed the phase 3 reference panel of the 1000 Genomes Project (1KGPp3) for Japanese samples, and IKJPN showed similar imputation rates for the TMM and other Japanese samples for SNPs with minor allele frequencies (MAFs) higher than 1%. CONCLUSIONS: 1KJPN covered most of the variants found in the samples from areas of the Japanese mainland outside the Miyagi region, implying 1KJPN is representative of the Japanese population's genomes. 1KJPN and successive reference panels are useful genome reference panels for the mainland Japanese population. Importantly, the addition of whole genome sequences not included in the 1KJPN panel improved imputation efficiencies for SNPs with MAFs under 1% for samples from most regions of the Japanese archipelago.

  20. The Tohoku Medical Megabank Project: Design and Mission 査読有り

    Shinichi Kuriyama, Nobuo Yaegashi, Fuji Nagami, Tomohiko Arai, Yoshio Kawaguchi, Noriko Osumi, Masaki Sakaida, Yoichi Suzuki, Keiko Nakayama, Hiroaki Hashizume, Gen Tamiya, Hiroshi Kawame, Kichiya Suzuki, Atsushi Hozawa, Naoki Nakaya, Masahiro Kikuya, Hirohito Metoki, Ichiro Tsuji, Nobuo Fuse, Hideyasu Kiyomoto, Junichi Sugawara, Akito Tsuboi, Shinichi Egawa, Kiyoshi Ito, Koichi Chida, Tadashi Ishii, Hiroaki Tomita, Yasuyuki Taki, Naoko Minegishi, Naoto Ishii, Jun Yasuda, Kazuhiko Igarashi, Ritsuko Shimizu, Masao Nagasaki, Seizo Koshiba, Kengo Kinoshita, Soichi Ogishima, Takako Takai-Igarashi, Teiji Tominaga, Osamu Tanabe, Noriaki Ohuchi, Toru Shimosegawa, Shigeo Kure, Hiroshi Tanaka, Sadayoshi Ito, Jiro Hitomi, Kozo Tanno, Motoyuki Nakamura, Kuniaki Ogasawara, Seiichiro Kobayashi, Kiyomi Sakata, Mamoru Satoh, Atsushi Shimizu, Makoto Sasaki, Ryujin Endo, Kenji Sobue, Masayuki Yamamoto

    JOURNAL OF EPIDEMIOLOGY 26 (9) 493-511 2016年9月

    DOI: 10.2188/jea.JE20150268  

    ISSN:0917-5040

  21. Erratum to: Induction of the Matrix Metalloproteinase 13 Gene in Bronchial Epithelial Cells by Interferon and Identification of its Novel Functional Polymorphism. 査読有り

    Mashimo Y, Sakurai-Yageta M, Watanabe M, Arima T, Morita Y, Inoue Y, Sato K, Nishimuta T, Suzuki S, Watanabe H, Hoshioka A, Tomiita M, Yamaide A, Kohno Y, Okamoto Y, Shimojo N, Hata A, Suzuki Y

    Inflammation 39 (3) 963 2016年6月

    DOI: 10.1007/s10753-016-0334-2  

    ISSN:0360-3997

  22. Induction of the Matrix Metalloproteinase 13 Gene in Bronchial Epithelial Cells by Interferon and Identification of its Novel Functional Polymorphism (vol 39, pg 949, 2016) 査読有り

    Yoichi Mashimo, Mika Sakurai-Yageta, Misa Watanabe, Takayasu Arima, Yoshinori Morita, Yuzaburo Inoue, Kazuki Sato, Toshiyuki Nishimuta, Shuichi Suzuki, Hiroko Watanabe, Akira Hoshioka, Minako Tomiita, Akiko Yamaide, Yoichi Kohno, Yoshitaka Okamoto, Naoki Shimojo, Akira Hata, Yoichi Suzuki

    INFLAMMATION 39 (3) 963-963 2016年6月

    DOI: 10.1007/s10753-016-0334-2  

    ISSN:0360-3997

    eISSN:1573-2576

  23. Xanthohumol inhibits STAT3 activation pathway leading to growth suppression and apoptosis induction in human cholangiocarcinoma cells 査読有り

    Hasaya Dokduang, Puangrat Yongvanit, Nisana Namwat, Chawalit Pairojkul, Sakkarn Sangkhamanon, Mika Sakurai Yageta, Yoshinori Murakami, Watcharin Loilome

    ONCOLOGY REPORTS 35 (4) 2065-2072 2016年4月

    DOI: 10.3892/or.2016.4584  

    ISSN:1021-335X

    eISSN:1791-2431

  24. Dynamic Regulation of a Cell Adhesion Protein Complex Including CADM1 by Combinatorial Analysis of FRAP with Exponential Curve-Fitting 査読有り

    Mika Sakurai-Yageta, Tomoko Maruyama, Takashi Suzuki, Kazuhisa Ichikawa, Yoshinori Murakami

    PLOS ONE 10 (3) e0116637 2015年3月

    DOI: 10.1371/journal.pone.0116637  

    ISSN:1932-6203

  25. Genomic and transcriptional alterations of cholangiocarcinoma 査読有り

    Takeshi Ito, Mika Sakurai-Yageta, Akiteru Goto, Chawalit Pairojkul, Puangrat Yongvanit, Yoshinori Murakami

    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES 21 (6) 380-387 2014年6月

    DOI: 10.1002/jhbp.67  

    ISSN:1868-6974

    eISSN:1868-6982

  26. Trans-Homophilic Interaction of CADM1 Activates PI3K by Forming a Complex with MAGuK-Family Proteins MPP3 and Dlg 査読有り

    Shigefumi Murakami, Mika Sakurai-Yageta, Tomoko Maruyama, Yoshinori Murakami

    PLOS ONE 9 (2) e110062 2014年2月

    DOI: 10.1371/journal.pone.0082894  

    ISSN:1932-6203

  27. Involvement of miR-214 and miR-375 in malignant features of Non-small-cell lung cancer by down-regulating CADM1 査読有り

    Ishimura M, Sakurai-Yageta M, Maruyama T, Ando T, Fukayama M, Goto A, Murakami Y

    Journal of Cancer Therapy 3 (4A) 379-387 2012年9月

    DOI: 10.4236/jct.2012.324050  

  28. Aberrant expression of tumor suppressors CADM1 and 4.1B in invasive lesions of primary breast cancer 査読有り

    Yuka Takahashi, Miwako Iwai, Taketo Kawai, Atsushi Arakawa, Takeshi Ito, Mika Sakurai-Yageta, Akihiko Ito, Akiteru Goto, Mitsue Saito, Fujio Kasumi, Yoshinori Murakami

    BREAST CANCER 19 (3) 242-252 2012年7月

    DOI: 10.1007/s12282-011-0272-7  

    ISSN:1340-6868

  29. Expression of a splicing variant of the CADM1 specific to small cell lung cancer 査読有り

    Shinji Kikuchi, Miwako Iwai, Mika Sakurai-Yageta, Yumi Tsuboi, Takeshi Ito, Tomoko Maruyama, Hitoshi Tsuda, Yae Kanai, Masataka Onizuka, Yukio Sato, Yoshinori Murakami

    CANCER SCIENCE 103 (6) 1051-1057 2012年6月

    DOI: 10.1111/j.1349-7006.2012.02277.x  

    ISSN:1347-9032

  30. Aberrations of a cell adhesion molecule CADM4 in renal clear cell carcinoma 査読有り

    Masayoshi Nagata, Mika Sakurai-Yageta, Daisuke Yamada, Akiteru Goto, Akihiko Ito, Hiroshi Fukuhara, Haruki Kume, Teppei Morikawa, Masashi Fukayama, Yukio Homma, Yoshinori Murakami

    INTERNATIONAL JOURNAL OF CANCER 130 (6) 1329-1337 2012年3月

    DOI: 10.1002/ijc.26160  

    ISSN:0020-7136

  31. Transcriptional regulation of the CADM1 gene by retinoic acid during the neural differentiation of murine embryonal carcinoma P19 cells 査読有り

    Takeshi Ito, Yuko Williams-Nate, Miwako Iwai, Yumi Tsuboi, Man Hagiyama, Akihiko Ito, Mika Sakurai-Yageta, Yoshinori Murakami

    GENES TO CELLS 16 (7) 791-802 2011年7月

    DOI: 10.1111/j.1365-2443.2011.01525.x  

    ISSN:1356-9597

  32. Tumor suppressor CADM1 is involved in epithelial cell structure 査読有り

    Mika Sakurai-Yageta, Mari Masuda, Yumi Tsuboi, Akihiko Ito, Yoshinori Murakami

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 390 (3) 977-982 2009年12月

    DOI: 10.1016/j.bbrc.2009.10.088  

    ISSN:0006-291X

  33. The interaction of IQGAP1 with the exocyst complex is required for tumor cell invasion downstream of Cdc42 and RhoA 査読有り

    Mika Sakurai-Yageta, Chiara Recchi, Gaelle Le Dez, Jean-Baptiste Sibarita, Laurent Daviet, Jacques Camonis, Crislyn D'Souza-Schorey, Philippe Chavrier

    JOURNAL OF CELL BIOLOGY 181 (6) 985-998 2008年6月

    DOI: 10.1083/jcb.200709076  

    ISSN:0021-9525

  34. Cell adhesion and prostate tumor-suppressor activity of TSLL2/IGSF4C, an immunoglobulin superfamily molecule homologous to TSLC1/IGSF4 査読有り

    YN Williams, M Masuda, M Sakurai-Yageta, T Maruyama, M Shibuya, Y Murakami

    ONCOGENE 25 (10) 1446-1453 2006年3月

    DOI: 10.1038/sj.onc.1209192  

    ISSN:0950-9232

  35. Promoter hypermethylation of the potential tumor suppressor DAL-1/4.1B gene in renal clear cell carcinoma 査読有り

    D Yamada, S Kikuchi, YN Williams, M Sakurai-Yageta, M Masuda, T Maruyama, K Tomita, DH Gutmann, T Kakizoe, T Kitamura, Y Kanai, Y Murakami

    INTERNATIONAL JOURNAL OF CANCER 118 (4) 916-923 2006年2月

    DOI: 10.1002/ijc.21450  

    ISSN:0020-7136

  36. Tumor suppressor in lung cancer (TSLC)1 suppresses epithelial cell scattering and tubulogenesis 査読有り

    M Masuda, S Kikuchi, T Maruyama, M Sakurai-Yageta, YN Williams, HP Ghosh, Y Murakami

    JOURNAL OF BIOLOGICAL CHEMISTRY 280 (51) 42164-42171 2005年12月

    DOI: 10.1074/jbc.M507136200  

    ISSN:0021-9258

  37. Promoter methylation of DAL-1/4.1B predicts poor prognosis in non-small cell lung cancer 査読有り

    S Kikuchi, D Yamada, T Fukami, M Masuda, M Sakurai-Yageta, YN Williams, T Maruyama, H Asamura, Y Matsuno, M Onizuka, Y Murakami

    CLINICAL CANCER RESEARCH 11 (8) 2954-2961 2005年4月

    DOI: 10.1158/1078-0432.CCR-04-2206   10.1158/1078-0432.ccr-04-2206  

    ISSN:1078-0432

  38. Detection of allelic imbalance in the gene expression of hMSH2 or RB1 in lymphocytes from pedigrees of hereditary, nonpolyposis, colorectal cancer and retinoblastoma by an RNA difference plot 査読有り

    Yoshinori Murakami, Kana Isogai, Hiroyuki Tomita, Mika Sakurai-Yageta, Tomoko Maruyama, Akio Hidaka, Kiyoshi Nose, Kokichi Sugano, Akihiro Kaneko

    Journal of Human Genetics 49 (11) 635-641 2004年11月

    DOI: 10.1007/s10038-004-0201-0  

    ISSN:1434-5161

  39. Detection of allelic imbalance in the gene expression of hMSH2 or RB1 in lymphocytes from pedigrees of hereditary, nonpolyposis, colorectal cancer and retinoblastoma by an RNA difference plot 査読有り

    Y Murakami, K Isogai, H Tomita, M Sakurai-Yageta, T Maruyama, A Hidaka, K Nose, K Sugano, A Kaneko

    JOURNAL OF HUMAN GENETICS 49 (11) 635-641 2004年11月

    DOI: 10.1007/s10038-004-0201-0  

    ISSN:1435-232X

  40. Isolation of the mouse Tsll1 and Tsll2 genes, orthologues of the human TSLC1-like genes 1 and 2 (TSLL1 and TSLL2) 査読有り

    T Fukami, H Satoh, YN Williams, M Masuda, H Fukuhara, T Maruyama, M Yageta, M Kuramochi, S Takamoto, Y Murakami

    GENE 323 11-18 2003年12月

    DOI: 10.1016/j.gene.2003.09.018  

    ISSN:0378-1119

  41. Association of a lung tumor suppressor TSLC1 with MPP3, a human homologue of Drosophila tumor suppressor Dlg 査読有り

    H Fukuhara, M Masvuda, M Yageta, T Fukami, M Kuramochi, T Maruyama, T Kitamura, Y Murakami

    ONCOGENE 22 (40) 6160-6165 2003年9月

    DOI: 10.1038/sj.onc.1206744  

    ISSN:0950-9232

  42. Direct association of TSLC1 and DAL-1, two distinct tumor suppressor proteins in lung cancer 査読有り

    M Yageta, M Kuramochi, M Masuda, T Fukami, H Fukuhara, T Maruyama, M Shibuya, Y Murakami

    CANCER RESEARCH 62 (18) 5129-5133 2002年9月

    ISSN:0008-5472

  43. The tumor suppressor protein TSLC1 is involved in cell-cell adhesion 査読有り

    M Masuda, M Yageta, H Fukuhara, M Kuramochi, T Maruyama, A Nomoto, Y Murakami

    JOURNAL OF BIOLOGICAL CHEMISTRY 277 (34) 31014-31019 2002年8月

    DOI: 10.1074/jbc.M203620200  

    ISSN:0021-9258

  44. Cdc6 requires anchorage for its expression 査読有り

    S Jinno, M Yageta, A Nagata, H Okayama

    ONCOGENE 21 (11) 1777-1784 2002年3月

    DOI: 10.1038/sj/onc/1205249  

    ISSN:0950-9232

  45. Oncogenic cell cycle start control 査読有り

    S Jinno, J Lin, M Yageta, H Okayama

    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS 477 (1-2) 23-29 2001年6月

    DOI: 10.1016/S0027-5107(01)00092-6   10.1016/s0027-5107(01)00092-6  

    ISSN:0027-5107

  46. The adenovirus E1A domains required for induction of DNA rereplication in G(2)/M arrested cells coincide with those required for apoptosis 査読有り

    M Yageta, H Tsunoda, T Yamanaka, T Nakajima, Y Tomooka, N Tsuchida, K Oda

    ONCOGENE 18 (34) 4767-4776 1999年8月

    DOI: 10.1038/sj.onc.1203063  

    ISSN:0950-9232

  47. Effects of wild-type and mutated p53 and Id proteins on the induction of apoptosis by adenovirus E1A, c-Myc, Bax, and Nip3 in p53 null mouse cerebellum cells 査読有り

    H Tsunoda, T Terasawa, M Yageta, T Nakajima, Y Tomooka, N Tsuchida, K Oda

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 255 (3) 722-730 1999年2月

    DOI: 10.1006/bbrc.1999.0143  

    ISSN:0006-291X

  48. Suppression of adenovirus E1A-induced apoptosis by mutated p53 is overcome by coexpression with Id proteins 査読有り

    T Nakajima, M Yageta, K Shiotsu, K Morita, M Suzuki, Y Tomooka, K Oda

    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 95 (18) 10590-10595 1998年9月

    DOI: 10.1073/pnas.95.18.10590  

    ISSN:0027-8424

︎全件表示 ︎最初の5件までを表示

MISC 26

  1. 東北メディカル・メガバンク計画における遺伝情報返却の課題

    濱中洋平, 濱中洋平, 大根田絹子, 布施昇男, 川目裕, 川目裕, 長神風二, 鈴木吉也, 鈴木洋一, 鈴木洋一, 佐藤政文, 平塚真弘, 櫻井美佳, 宇留野晃, 山口由美, 平良摩紀子, 山本雅之, 濱中洋平, 濱中洋平

    日本人類遺伝学会大会プログラム・抄録集 65th (CD-ROM) 2020年

  2. ゲノムコホート調査参加者に対するゲノム薬理学(PGx)遺伝情報の返却(回付)-PGxの知識・理解に関する調査票解析

    大根田絹子, 布施昇男, 川目裕, 川目裕, 長神風二, 鈴木吉也, 鈴木洋一, 鈴木洋一, 佐藤政文, 櫻井美佳, 宇留野晃, 濱中洋平, 平良摩紀子, 平塚真弘, 山本雅之, 山本雅之

    日本人類遺伝学会大会プログラム・抄録集 65th (CD-ROM) 2020年

  3. AMEDにおけるゲノム医療実現に向けた新たなアプローチ -データシェアリングポリシーの策定とその舞台裏-

    三成 寿作, 加藤 治, 櫻井 美佳, 齋藤 あき

    遺伝子医学MOOK 33号 2018年4月

  4. ゲノムコホート研究に基づく腎臓病学

    櫻井 美佳, 清元 秀泰

    腎臓内科・泌尿器科 7 (2) 115-120 2018年2月

    ISSN: 2188-9147

  5. 細胞接着分子CADM1複合体の動態解明―指数関数あてはめを用いたFRAPデータの解析

    伊東 剛, 櫻井(八下田, 美佳, 村上善則

    35 (5) 2017年3月

  6. 「遺伝の仕組み」と「多様性」を学ぶための小児を対象とした遺伝教育ツール開発の取り組み

    小林朋子, 小林朋子, 菅原美智子, 石原利乃, 本郷一夫, 相澤弥生, 山口由美, 齋藤さかえ, 田中由佳里, 栗木美穂, 長神風二, 安田純, 櫻井美佳, 栗山進一, 川目裕, 鈴木吉也, 山本雅之, 鈴木洋一, 鈴木洋一

    日本人類遺伝学会大会プログラム・抄録集 62nd 324 2017年

  7. 東北メディカル・メガバンク計画とゲノム研究の展望

    櫻井 美佳, 清元 秀泰

    腎臓内科・泌尿器科 5 (1) 87-93 2017年1月

    ISSN: 2188-9147

  8. 肺腺がん細胞の実験的転移系を用いた転移関連分子の同定と機能解析

    熊谷 友紀, 伊東 剛, 永田 政義, 川合 剛人, 丸山 智子, 櫻井 美佳, 八下田, 後藤 明輝, 松原 大祐, 村上 善則

    日本癌学会総会記事 74回 J-1269 2015年10月

    出版者・発行元: 日本癌学会

    ISSN: 0546-0476

  9. Analysis of the role of CADM1 in suppression of lung cancer using Cadm1-deficient mice

    Takeshi Ito, Masayoshi Nagata, Taketo Kawai, Mika Sakurai-Yageta, Akihiko Ito, Akiteru Goto, Daisuke Matsubara, Yoshinori Murakami

    CANCER RESEARCH 75 2015年8月

    DOI: 10.1158/1538-7445.AM2015-2302  

    ISSN: 0008-5472

    eISSN: 1538-7445

  10. Trans-Homophilic Interaction of CADM1 Activates PI3K by Forming a Complex with MAGuK-Family Proteins MPP3 and Dlg (vol 9, e82894, 2014)

    S. Murakami, M. Sakurai-Yageta, T. Maruyama, Y. Murakami

    PLOS ONE 9 (9) 2014年9月

    DOI: 10.1371/journal.pone.0110062  

    ISSN: 1932-6203

  11. 遺伝子欠損マウスを用いたCADM1の肺腫瘍抑制における役割の解明(Analysis of the role of CADM1 in suppression of lung cancer using Cadm1-deficient mice)

    伊東 剛, 永田 政義, 川合 剛人, 丸山 智子, 櫻井 美佳, 八下田, 伊藤 彰彦, 後藤 明輝, 松原 大祐, 村上 善則

    日本癌学会総会記事 73回 P-2021 2014年9月

    出版者・発行元: 日本癌学会

    ISSN: 0546-0476

  12. 肺腺がん細胞株の実験的肺転移における遺伝子発現変動を指標として抽出される転移関連因子の探索(Screening of metastasis-related genes by microarray analysis of lung cancer cells using experimental lung metastasis)

    熊谷 友紀, 伊東 剛, 永田 政義, 川合 剛人, 丸山 智子, 櫻井 美佳, 八下田, 後藤 明輝, 松原 大祐, 村上 善則

    日本癌学会総会記事 73回 P-3133 2014年9月

    出版者・発行元: 日本癌学会

    ISSN: 0546-0476

  13. EXPRESSION OF A SPLICING VARIANT OF THE CADM1 SPECIFIC TO SMALL CELL LUNG CANCER

    Shinji Kikuchi, Miwako Iwai, Mika Sakurai-Yageta, Yumi Tsuboi, Takeshi Ito, Tomoko Maruyama, Hitoshi Tsuda, Yae Kanai, Yukinobu Goto, Mitsuaki Sakai, Masataka Onizuka, Yukio Sato, Yoshinori Murakami

    JOURNAL OF THORACIC ONCOLOGY 8 S754-S754 2013年11月

    ISSN: 1556-0864

    eISSN: 1556-1380

  14. 遺伝子欠損マウスを用いたCADM1の肺腫瘍抑制における役割の解明(Analysis of the role of CADM1 in suppression of lung cancer development using Cadm1-deficient mice)

    伊東 剛, 永田 政義, 川合 剛人, 丸山 智子, 櫻井 美佳, 八下田, 伊藤 彰彦, 後藤 明輝, 松原 大祐, 村上 善則

    日本癌学会総会記事 71回 246-246 2012年8月

    出版者・発行元: 日本癌学会

    ISSN: 0546-0476

  15. 肺腺がんのEGFR-TK阻害剤に対する耐性獲得における細胞接着分子CADM1の役割(Possible involvement of a cell adhesion molecule, CADM1 in acquired resistance of lung adenocarcinoma to EGFR-TKIs)

    桑野 秀規, 岩井 美和子, 川合 剛人, 伊東 剛, 桜井 美佳, 八下田, 後藤 明輝, 小泉 史明, 中島 淳, 田村 研治, 村上 善則

    日本癌学会総会記事 71回 442-442 2012年8月

    出版者・発行元: 日本癌学会

    ISSN: 0546-0476

  16. がん研究への病理学の新しい関わり方 分子病理学的解析が示す細胞接着分子CADM1のヒト肺癌における抑制、促進両面の役割(Concurrent integration of pathology and cancer research Dual roles of a cell adhesion molecule, CADM1, in lung oncogenesis based on the molecular pathological analyses)

    村上 善則, 桜井 美佳, 伊東 剛, 桑野 秀規, 松原 大祐, 後藤 明輝

    日本癌学会総会記事 71回 450-450 2012年8月

    出版者・発行元: 日本癌学会

    ISSN: 0546-0476

  17. 肺腺がん細胞株の実験的肺転移における遺伝子発現変動を指標として抽出される転移関連因子の探索(Screening of metastasis-related genes by microarray analysis of lung cancer cells using experimental lung metastasis)

    熊谷 友紀, 伊東 剛, 永田 政義, 川合 剛人, 丸山 智子, 櫻井 美佳, 八下田, 後藤 明輝, 村上 善則

    日本癌学会総会記事 71回 487-487 2012年8月

    出版者・発行元: 日本癌学会

    ISSN: 0546-0476

  18. 肝吸虫関連および非関連肝内胆管癌におけるCADM1の発現 日本及びタイ症例の比較研究(Loss of CADM1 expression in cholangiocarcinoma related and unrelated to liver fluke infection)

    後藤 明輝, 櫻井 美佳, 八下田, Pairojkul Chawalit, Yongvanit Puangrat, 柴原 純二, 深山 正久, 村上 善則

    日本癌学会総会記事 70回 303-303 2011年9月

    出版者・発行元: 日本癌学会

    ISSN: 0546-0476

  19. 乳がんの進展、再発に関わる細胞接着分子CADM1、並びに新規分子標的の解析(Identification of molecular targets involved in the progression and recurrence of breast cancer)

    村上 善則, 高橋 由佳, 岩井 美和子, 荒川 敦, 伊東 剛, 櫻井 美佳, 八下田, 伊藤 彰彦, 後藤 明輝, 伊東 紀子, 江見 充, 齋藤 光江, 霞 富士雄

    日本癌学会総会記事 70回 215-215 2011年9月

    出版者・発行元: 日本癌学会

    ISSN: 0546-0476

  20. miR-375およびmiR-214/199aによるCADM1の発現抑制とそのがん化への関与(Suppression of CADM1 expression by miR-375 and miR-214/199a and its role in tumorigenesis)

    石村 恵, 櫻井 美佳, 八下田, 後藤 明輝, 村上 善則

    日本癌学会総会記事 70回 269-269 2011年9月

    出版者・発行元: 日本癌学会

    ISSN: 0546-0476

  21. Spontaneous development of lung adenocarcinoma in the CADM1 gene-deficient mice. 査読有り

    Nagata M, Sakurai-Yageta M, Yamada D, Kawai T, Tsuboi Y, Ito T, Ito A, Yoshida M, Murakami Y

    BMC Proceedings 2010年9月

    DOI: 10.1186/1753-6561-4-s2-o18  

  22. DISRUPTION OF CDM4-4.1B CASCADE OF CELL ADHESION IN RENAL CLEAR CELL CARCINOMA

    Masayoshi Nagata, Mika Sakurai-Yageta, Daisuke Yamada, Akihiko Ito, Haruki Kume, Teppei Morikawa, Yoshinori Murakami, Yukio Homma

    JOURNAL OF UROLOGY 183 (4) E141-E142 2010年4月

    DOI: 10.1016/j.juro.2010.02.424  

    ISSN: 0022-5347

    eISSN: 1527-3792

  23. Spontaeous development of lung adenocarcinoma in mice lacking the tumor suppressor gene, CADM1/TSLC1

    Yoshinori Murakami, Masayoshi Nagata, Daisuke Yamada, Mika Sakurai-Yageta, Miwako Iwai, Takashi Obana, Taketo Kawai, Mari Masuda, Yumi Tsuboi, Hiromi Ichihara, Tomoko Maruyama, Akihiko Ito

    CANCER RESEARCH 69 2009年5月

    ISSN: 0008-5472

    eISSN: 1538-7445

  24. Promoter methylation of the DAL-1/4.1B predicts poor prognosis in non-small cell lung cancer

    S Kikuchi, D Yamada, M Masuda, M Sakurai-Yageta, YN Williams, T Maruyama, H Asamura, Y Matsuno, M Onizuka, Y Murakami

    LUNG CANCER 49 S130-S130 2005年7月

    ISSN: 0169-5002

  25. TSLC1 affects HGF-induced cell motility of epithelial cells

    Mari Masuda, Mika Sakurai-Yageta, Yuko N. Williams, Tomoko Maruyama, O. Yoshinori Murakami

    CELL STRUCTURE AND FUNCTION 29 28-28 2004年5月

    ISSN: 0386-7196

    eISSN: 1347-3700

  26. Association of a lung tumor suppressor TSLC1 with MPP3, a human homologue of Drosophila tumor suppressor Dlg (vol 22, pg 6160, 2003)

    H Fukuhara, M Masuda, M Yageta, T Fukami, M Kuramochi, T Maruyama, T Kitamura, Y Murakami

    ONCOGENE 23 (2) 629-629 2004年1月

    DOI: 10.1038/sj.onc.1207365  

    ISSN: 0950-9232

︎全件表示 ︎最初の5件までを表示

共同研究・競争的資金等の研究課題 10

  1. 気道の炎症性疾患におけるビオチン輸送の役割

    櫻井 美佳

    提供機関:Japan Society for the Promotion of Science

    制度名:Grants-in-Aid for Scientific Research

    研究種目:Grant-in-Aid for Scientific Research (C)

    研究機関:Tohoku University

    2023年4月1日 ~ 2026年3月31日

    詳細を見る 詳細を閉じる

    申請者らはこれまで、ビオチンと気管支喘息やスギ花粉症を含む気道の炎症性疾患との関連を示してきた。また、ビオチンは、腸管上皮細胞の頂端膜面よりSMVT/SLC5A6輸送体を介して生体内に取り込まれるが、腸管特異的にこの輸送体の機能を欠如することにより、同部位での炎症誘発が報告されている。一方、取り込まれたビオチンを他の細胞・組織に輸送するのに必要な側基底膜面のビオチン輸送体は同定されておらず、ビオチンの気道への輸送制御およびそれが炎症に及ぼす影響は明らかになっていない。そこで本研究では、側基底膜面のビオチン輸送体を同定することにより全身へのビオチン輸送機構を明らかにし、さらに、その気道炎症における役割を解明することを目的とする。このため、ビオチン欠乏やSMVT発現抑制下での網羅的な遺伝子発現解析、およびSLC、ABC輸送体の中から候補遺伝子を選抜し、それらの発現を抑制した場合のビオチン輸送や細胞構造への影響から、側基底膜面のビオチン輸送体の同定を行う。 本年度は、ビオチンの側基底膜面の輸送体を同定するため、種々の細胞をビオチン欠乏、また頂端膜面の輸送体であるSMVT発現抑制下で培養し、膜タンパク質をコードし、かつ発現量が変化する遺伝子の探索を試みた。数日間のビオチン欠乏培養やSMVTの抑制により細胞の増殖や形態に影響を及ぼす細胞株、またビオチン欠乏下でSMVT遺伝子の発現変化を示す細胞株を選定した。

  2. 分子疫学研究による胆のうがんリスク要因の解明

    菊地 正悟, 上野 誠, 中杤 昌弘, 笹平 直樹, 米澤 英雄, 櫻井 美佳, 大崎 敬子

    提供機関:Japan Society for the Promotion of Science

    制度名:Grants-in-Aid for Scientific Research

    研究種目:Grant-in-Aid for Scientific Research (B)

    研究機関:Aichi Medical University

    2021年4月1日 ~ 2024年3月31日

    詳細を見る 詳細を閉じる

    胆のうがんの発がん要因は何か、慢性感染症・生活習慣など環境要因や遺伝的要因は相互にどのように影響し合いながら胆のうの発がんに作用しているかを明らかにする研究である。 1. 遺伝子については、IL1-βなど炎症反応関連遺伝子、喫煙の影響に関連する遺伝子(CYP1A1、GSTなど)、アルコール代謝関連遺伝子(ADH, ALDH2)、肥満関連遺伝子 (FTO) などや、応募者らの研究で膵がんとの関連が明らかになったGP2遺伝子に加え、これまで他部位のがんリスクとの関連が明らかになっている遺伝子を中心に、炎症、解毒・代謝系に関わる遺伝子をリストアップを進めている。 2. GWASは、当初業者委託を予定していたが、データベースの利用などを考慮し、櫻井(分担研究者・東北大学東北メガバンク機構)に加わってもらって実施することとなった。2021年度胆嚢がん検体が155例、対照325例について、GWASの測定を行った。対照は、検出力を考え、余分に測定した。Imputation(測定されなかったSNPの補完)を含めたデータの解析は2022年度に行う計画である。 3. これまで開発したH. bilis とH. hepaticus 抗体で測定した結果を論文として公表した。これらの感染が発がんを促進していることを疑わせる結果であるが、確定的なものとはなっていない。このことから、抗体測定系にについて、改良が必要と考えられ、その方向で研究を進めることとなった。 4. 症例収集施設の倫理委員会等の承認を得て、症例収集を再開している。 5. 班会議をリモートで1回開催した。

  3. GWASで同定した新規膵がん感受性遺伝子GP2に関する分子遺伝疫学研究

    林 櫻松, 中杤 昌弘, 櫻井 美佳

    提供機関:Japan Society for the Promotion of Science

    制度名:Grants-in-Aid for Scientific Research

    研究種目:Grant-in-Aid for Scientific Research (B)

    研究機関:Aichi Medical University

    2021年4月1日 ~ 2024年3月31日

    詳細を見る 詳細を閉じる

    ① GP2 遺伝子多型と生活習慣の関連:愛知医大が主導で行っている多施設膵がん症例対照研究により収集した膵がん620例とコントロール400例を対象として、GP2の原因候補遺伝子多型であるrs78193826とBMI、糖尿病の関連を検討した。rs78193826多型がCC型の人のBMI平均値は22.9±3.3、CTまたはTT型の人の平均値は22.8±3.0と両者の間に統計学的有意差が認められなかった。一方で、CC型と比べて、CTまたはTT型を持つ人で糖尿病の割合が有意に高い(14.8% 対 22.8%)ことが明らかになった。 <BR> ② ファインマッピングでは、GP2領域の原因候補遺伝子多型を絞りこむために、アメリカNCI PanScan (膵がんコンソーシアム)及びPanc4 (膵がん症例対照研究コンソーシアム)と共同研究契約を締結し、膵がん症例約8000例、コントロール約10000人のサマリーデータを入手した。 <BR> <BR> ③ GP2領域のターゲットリシーケンシングについては、理研ジェネシスなど2社に見積もりを依頼したが、本研究課題の予算では実施困難と判明した。また、文部科学省「先進ゲノム支援」に申請したものの、採択に至らなかった。

  4. 左室駆出率が保持された心不全に対する個別化医療を目指した多分野融合研究

    安斉 俊久, 永井 利幸, 小川 貴弘, 横田 勲, 清水 厚志, 平田 健司, 小柴 生造, 櫻井 美佳

    提供機関:Japan Society for the Promotion of Science

    制度名:Grants-in-Aid for Scientific Research

    研究種目:Grant-in-Aid for Scientific Research (B)

    研究機関:Hokkaido University

    2020年4月1日 ~ 2024年3月31日

    詳細を見る 詳細を閉じる

    HFpEF計500症例を目標に以下の組み入れ基準・除外基準で北海道大学病院を含む全国24施設からElectronic Data Captureシステムを用いて詳細な臨床情報を含めて登録し、各種解析を並行して実施した。組み入れ基準:外来もしくは入院心不全症例:①20歳以上でフラミンガム心不全診断基準を満足する心不全症状/所見があり、②左室駆出率50%以上かつBNP値100pg/mLを超えるもしくはN末端proBNP値400 pg/mLを超える、③本人からの文書同意が可能。除外基準:①敗血症、②心筋炎、③閉塞型肥大型心筋症、④拘束型心筋症、⑤重度の弁膜症、⑥心臓移植後あるいは待機、⑦1か月以内の予定心臓手術各種解析:①心不全マルチバイオマーカー解析 ②アレイ(ゲノムワイド関連)解析 ③網羅的メタボローム解析 ④人工知能解析 今年度は昨年度に引き続き、上記基準に該当する心不全症例の登録を開始してきた。令和4年3月末の時点で、目標症例数を超えるHFpEF664例の登録が得られ、バイオマーカー、アレイ、メタボローム解析も完了した。また、歩行動画の統一条件撮影に関しては昨年度特許申請に至った撮影アプリケーションを用いて現在歩行動画が回収できた192例に対し、歩行パターンの機械学習によるクラスター解析を行っており、教師なし学習で臨床医が判定した臨床フレイルスケールを高い弁別能で予測出来ることに加え、予後との関連も明らかになりつつある。

  5. ビオチン代謝によるアレルギー性気道炎症の制御メカニズムの解明 競争的資金

    櫻井 美佳

    2016年4月 ~ 2019年3月

  6. 細胞コンテクスト依存的細胞接着分子機能の解析に基づく、固形がんの個性診断法の開発

    村上 善則, 松原 大祐, 後藤 明輝, 櫻井 美佳

    提供機関:Japan Society for the Promotion of Science

    制度名:Grants-in-Aid for Scientific Research

    研究種目:Grant-in-Aid for Scientific Research (B)

    研究機関:The University of Tokyo

    2013年4月1日 ~ 2016年3月31日

    詳細を見る 詳細を閉じる

    増殖因子HGFの受容体METは、様々ながんで遺伝子増幅、過剰発現等の活性化により、がん遺伝子として作用し、がん細胞の増殖や上皮間葉転換、薬剤抵抗性の獲得を促進する。申請者らは、細胞接着分子CADM1が細胞膜ラフト上でMETと複合体を形成し、そのシグナルを抑制することを見出した。さらに、CADM1は多くのがんで不活化していることから、METが活性化しCADM1が不活化したある種のがん細胞において、CADM1を実験的に導入、発現させることによりMETシグナルが抑制されることを見出した。CADM1は、がん細胞の悪性化を抑制する新たな分子標的と考えられる。

  7. 生体イメージングを用いた細胞接着分子CADM1のがん化における役割の解析 競争的資金

    櫻井 美佳

    2012年4月 ~ 2015年3月

  8. 細胞接着分子群の解析に基づく、がんの個性診断法の開発 競争的資金

    村上 善則

    2010年4月 ~ 2013年3月

  9. Ig様接着分子CADM1による細胞間接着と浸潤における動態と下流分子経路の解明 競争的資金

    櫻井 美佳

    2009年4月 ~ 2012年3月

  10. がん関連遺伝子の構造、発現、機能解析によるがんの分子診断と病態の解明 競争的資金

    村上 善則

    2005年4月 ~ 2010年3月

︎全件表示 ︎最初の5件までを表示